11/08/2024
1:17 PM | Anika Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
11/04/2024
3:41 PM | Anika Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
6:20 AM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
6:16 AM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:06 PM | Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
4:21 PM | Anika Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/11/2024
3:35 PM | Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/11/2024
3:31 PM | Anika Therapeutics (Issuer)
Capper Joseph H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:32 PM | Anika Therapeutics (Issuer)
CONLEY SHERYL L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:32 PM | Anika Therapeutics (Issuer)
Fischetti Gary P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:33 PM | Anika Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:33 PM | Anika Therapeutics (Issuer)
Jellison William R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:34 PM | Anika Therapeutics (Issuer)
Larsen Glenn R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:34 PM | Anika Therapeutics (Issuer)
Richard Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:24 PM | Anika Therapeutics (Filer)
| Form DEFA14A | |
06/05/2024
3:10 PM | Anika Therapeutics (Issuer)
Capper Joseph H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:10 PM | Anika Therapeutics (Issuer)
Griffin Stephen D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:11 PM | Anika Therapeutics (Issuer)
Jellison William R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:31 PM | Anika Therapeutics (Subject)
Caligan Partners LP (Filed by)
| Form SC 13D/A | |
05/28/2024
4:04 PM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
4:15 PM | Anika Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
3:12 PM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
7:48 AM | Anika Therapeutics (Filer)
| Form 10-K/A | |
04/05/2024
11:21 AM | Anika Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
03/19/2024
4:23 PM | Anika Therapeutics (Issuer)
Levitz Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:20 AM | Anika Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
3:10 PM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
7:01 PM | Anika Therapeutics (Issuer)
Levitz Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:02 PM | Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:03 PM | Anika Therapeutics (Issuer)
Colleran David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:04 PM | Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:30 PM | Anika Therapeutics (Subject)
Caligan Partners LP (Filed by)
| Form SC 13D/A | |
02/26/2024
8:00 AM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
10:09 AM | Anika Therapeutics (Subject)
Trigran Investments, Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024
1:27 PM | Anika Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/22/2024
9:52 AM | Anika Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
8:29 AM | Anika Therapeutics (Filer)
| Form S-8 POS | |
01/19/2024
3:52 PM | Anika Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/12/2024
3:35 PM | Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
| Form 3/A | |
